Boston Scientific (BSX) Other Non-Current Liabilities (2009 - 2026)

Boston Scientific (BSX) has 18 years of Other Non-Current Liabilities data on file, last reported at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 26.88% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 26.88% YoY), and the FY2025 full-year result was $2.4 billion, up 28.61% from the prior year.
• Other Non-Current Liabilities climbed to $2.5 billion in Q1 2026, from $2.4 billion in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $2.5 billion in Q1 2026 to a low of $1.8 billion in Q2 2024.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities slipped 16.55% in 2022 and soared 32.39% in 2025, its largest moves.
• Tracing BSX's Other Non-Current Liabilities over 5 years: stood at $2.0 billion in 2022, then decreased by 3.34% to $2.0 billion in 2023, then declined by 4.93% to $1.9 billion in 2024, then rose by 28.61% to $2.4 billion in 2025, then gained by 2.66% to $2.5 billion in 2026.
• Business Quant data shows BSX's Other Non-Current Liabilities at $2.5 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.